These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11721130)

  • 1. Recurrent myelitis associated with herpes simplex virus type 2.
    Gobbi C; Tosi C; Städler C; Merenda C; Bernasconi E
    Eur Neurol; 2001; 46(4):215-8. PubMed ID: 11721130
    [No Abstract]   [Full Text] [Related]  

  • 2. Herpes simplex virus: a new era?
    Van de Perre P; Nagot N
    Lancet; 2012 Feb; 379(9816):598-9. PubMed ID: 22226046
    [No Abstract]   [Full Text] [Related]  

  • 3. ACOG practice bulletin: Clinical management guidelines for obstetrician-gynecologists, number 57, November 2004. Gynecologic herpes simplex virus infections.
    ACOG Committee on Practice Bulletins--Gynecology
    Obstet Gynecol; 2004 Nov; 104(5 Pt 1):1111-8. PubMed ID: 15516420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of antiviral drugs to prevent herpesvirus transmission.
    Crumpacker CS
    N Engl J Med; 2004 Jan; 350(1):67-8. PubMed ID: 14702430
    [No Abstract]   [Full Text] [Related]  

  • 5. [Genital herpes].
    Kawana T
    Nihon Rinsho; 2009 Jan; 67(1):143-52. PubMed ID: 19177764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Suppressive therapy for genital herpes simplex virus infections].
    Sugase M
    Nihon Rinsho; 2006 Mar; 64 Suppl 3():316-20. PubMed ID: 16615491
    [No Abstract]   [Full Text] [Related]  

  • 7. [Herpes genitalis].
    Volpi A; Testore GP; Sarrecchia C
    Recenti Prog Med; 1999 Nov; 90(11):571-4. PubMed ID: 10608144
    [No Abstract]   [Full Text] [Related]  

  • 8. One-day regimen of valacyclovir for treatment of recurrent genital herpes simplex virus 2 infection.
    Bavaro JB; Drolette L; Koelle DM; Almekinder J; Warren T; Tyring S; Wald A
    Sex Transm Dis; 2008 Apr; 35(4):383-6. PubMed ID: 18362859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An international, randomized, double-blind, placebo-controlled, study of valacyclovir for the suppression of herpes simplex virus type 2 genital herpes in newly diagnosed patients.
    Fife KH; Warren TJ; Justus SE; Heitman CK;
    Sex Transm Dis; 2008 Jul; 35(7):668-73. PubMed ID: 18461016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppressive therapy with valacyclovir in early genital herpes: a pilot study of clinical efficacy and herpes-related quality of life.
    Handsfield HH; Warren T; Werner M; Phillips JA
    Sex Transm Dis; 2007 Jun; 34(6):339-43. PubMed ID: 17065847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Once-daily valacyclovir to reduce the risk of transmission of genital herpes.
    Corey L; Wald A; Patel R; Sacks SL; Tyring SK; Warren T; Douglas JM; Paavonen J; Morrow RA; Beutner KR; Stratchounsky LS; Mertz G; Keene ON; Watson HA; Tait D; Vargas-Cortes M;
    N Engl J Med; 2004 Jan; 350(1):11-20. PubMed ID: 14702423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valacyclovir. New indication: for genital herpes, simpler administration.
    Can Fam Physician; 1999 Jul; 45():1698-700, 1703-5. PubMed ID: 10424269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Genital herpes: epidemiology, transmission, clinic, asymptomatic viral excretion, impact on other sexually transmitted diseases, prevention, and treatment].
    Bossi P
    Ann Dermatol Venereol; 2002 Apr; 129(4 Pt 2):477-93. PubMed ID: 12122319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Herpes neolabialis: herpes simplex virus type 1 infection of the neolabia in a transgender woman.
    Elfering L; van der Sluis WB; Mermans JF; Buncamper ME
    Int J STD AIDS; 2017 Jul; 28(8):841-843. PubMed ID: 28632111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A large-scale, placebo-controlled, dose-ranging trial of peroral valaciclovir for episodic treatment of recurrent herpes genitalis. Valaciclovir HSV Study Group.
    Spruance SL; Tyring SK; DeGregorio B; Miller C; Beutner K
    Arch Intern Med; 1996 Aug 12-26; 156(15):1729-35. PubMed ID: 8694673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent developments in the management of herpes simplex virus infection in HIV-infected persons.
    Bartlett JG
    Clin Infect Dis; 2004 Nov; 39 Suppl 5():S237-9. PubMed ID: 15494894
    [No Abstract]   [Full Text] [Related]  

  • 17. Recalcitrant hypertrophic herpes genitalis in HIV-infected patient successfully treated with topical imiquimod.
    Tandon S; Singh J; Sinha S; Sharma DP
    Dermatol Ther; 2017 May; 30(3):. PubMed ID: 28261899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of valacyclovir on viral shedding in immunocompetent patients with recurrent herpes simplex virus 2 genital herpes: a US-based randomized, double-blind, placebo-controlled clinical trial.
    Fife KH; Warren TJ; Ferrera RD; Young DG; Justus SE; Heitman CK; Burroughs SM
    Mayo Clin Proc; 2006 Oct; 81(10):1321-7. PubMed ID: 17036557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of daily valacyclovir suppression on herpes simplex virus type 2 viral shedding in HSV-2 seropositive subjects without a history of genital herpes.
    Sperling RS; Fife KH; Warren TJ; Dix LP; Brennan CA
    Sex Transm Dis; 2008 Mar; 35(3):286-90. PubMed ID: 18157071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent cutaneous neonatal herpes caused by Herpes simplex virus-2.
    Imafuku S; Ohta E; Yoshimura K; Yasumoto S; Hirose S; Nakayama J
    J Dermatol; 2012 Jul; 39(7):671-2. PubMed ID: 21955135
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.